Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Alzheimer Disease and BDNF[original query] |
---|
Lack of association between the BDNF gene Val66Met polymorphism and Alzheimer disease in a Chinese Han population. Neuropsychobiology 2007 55 (3-4): 151-5. He Xiao-ming, Zhang Zhen-xin, Zhang Jun-wu, Zhou Yong-tao, Tang Mou-ni, Wu Cheng-bin, Hong Zh |
Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer disease and associated disorders 0 23 (3): 224-8. Fehér Agnes, Juhász Anna, Rimanóczy Agnes, Kálmán János, Janka Zolt |
Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 2011 Sep 11 (3): 141-9. Nagata Tomoyuki, Shinagawa Shunichiro, Nukariya Kazutaka, Ochiai Yusuke, Kawamura Satoshi, Agawa-Ohta Miyuki, Kasahara Hiroo, Nakayama Kazuhiko, Yamada Hisas |
The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Archives of general psychiatry 2011 Feb 68 (2): 198-206. Voineskos Aristotle N, Lerch Jason P, Felsky Daniel, Shaikh Sajid, Rajji Tarek K, Miranda Dielle, Lobaugh Nancy J, Mulsant Benoit H, Pollock Bruce G, Kennedy James |
Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease. Dementia and geriatric cognitive disorders 2012 33 (4): 266-72. Nagata Tomoyuki, Shinagawa Shunichiro, Nukariya Kazutaka, Yamada Hisashi, Nakayama Kazuhi |
Brain-derived neurotrophic factor gene variants and Alzheimer disease: an association study in an Alzheimer disease Italian population. Rejuvenation research 2013 Feb 16 (1): 57-66. Boiocchi Chiara, Maggioli Elisa, Zorzetto Michele, Sinforiani Elena, Cereda Cristina, Ricevuti Giovanni, Cuccia Mariacla |
Sertraline for the treatment of depression in Alzheimer disease: genetic influences. Journal of geriatric psychiatry and neurology 2011 Dec 24 (4): 222-8. Peters Matthew E, Vaidya Vijay, Drye Lea T, Rosenberg Paul B, Martin Barbara K, Porsteinsson Anton P, Frangakis Constantine E, Mintzer Jacobo, Weintraub Daniel, Schneider Lon S, Rabins Peter V, Munro Cynthia A, Meinert Curtis L, Lyketsos Constantine G, Avramopoulos Dimitri, Dimitri Avramopoulos, |
Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults. Journal of biomedical science 2013 20 (1): 57. Tonacci Alessandro, Borghini Andrea, Mercuri Antonella, Pioggia Giovanni, Andreassi Maria Graz |
Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. Journal of neural transmission (Vienna, Austria : 1996) 2013 Nov . Nagata T, Kobayashi N, Shinagawa S, Yamada H, Kondo K, Nakayama K |
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences. Journal of geriatric psychiatry and neurology 2015 Aug . Peters Matthew E, Vaidya Vijay, Drye Lea T, Devanand Davangere P, Mintzer Jacobo E, Pollock Bruce G, Porsteinsson Anton P, Rosenberg Paul B, Schneider Lon S, Shade David M, Weintraub Daniel, Yesavage Jerome, Lyketsos Constantine G, Avramopoulos Dimitri, |
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cognitive, affective & behavioral neuroscience 2015 Sep 15 (3): 625-43. Kim Ana, Fagan Anne M, Goate Alison M, Benzinger Tammie L S, Morris John C, Head Denise, |
BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention. Neurology 2017 May . Boots Elizabeth A, Schultz Stephanie A, Clark Lindsay R, Racine Annie M, Darst Burcu F, Koscik Rebecca L, Carlsson Cynthia M, Gallagher Catherine L, Hogan Kirk J, Bendlin Barbara B, Asthana Sanjay, Sager Mark A, Hermann Bruce P, Christian Bradley T, Dubal Dena B, Engelman Corinne D, Johnson Sterling C, Okonkwo Ozioma |
Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article. Medicine 2019 7 98 (30): e16604. Fang Yan, Du Naiyi, Xing Longyan, Duo Yali, Zheng L |
Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer disease and associated disorders 2020 6 34 (3): 212-219. Stojanovic Marta, Jin Yuxuan, Fagan Anne M, Benzinger Tammie L, Hassenstab Jason, Cruchaga Carlos, Morris John C, Head Deni |
Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. JAMA neurology 2022 Jan . Lim Yen Ying, Maruff Paul, Barthélemy Nicolas R, Goate Alison, Hassenstab Jason, Sato Chihiro, Fagan Anne M, Benzinger Tammie L S, Xiong Chengjie, Cruchaga Carlos, Levin Johannes, Farlow Martin R, Graff-Radford Neill R, Laske Christoph, Masters Colin L, Salloway Stephen, Schofield Peter R, Morris John C, Bateman Randall J, McDade Eric, |
Association between the Val66Met polymorphism (rs6265/G196A) of the BDNF gene and cognitive performance with SSRI use in Arab Alzheimer's disease patients. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2022 1 29 (12): 1392-1398. Abanmy N, Alsabhan J, Gard P, Scutt |
- Page last reviewed:Feb 1, 2024
- Content source: